Future of Medical Innovation

Interesting post and comments at Will Wilkinson's blog.

Profligate U.S. spending on state-of-the-art treatments acts as a subsidy to the health care systems of other countries, who get to free-ride off American innovation and (often “wasteful”) market experimentation.

That's right. Why haven't we heard more about this?

The hen that lays golden eggs requires a lot of chicken feed. That doesn't mean we should cook her. Then our goose would be cooked! Wait, that's not right... well, whatever.

0 comments: